CARM1 and non-small cell lung carcinoma: Wu et al. found that the expression of PRMT4 is elevated in non-small cell lung cancer (NSCLC), and silencing PRMT4 could reduce the proliferative activity of NSCLC cells (PC9 and HCC827), suggesting an oncogenic role for PRMT4 in NSCLC 17.